AAAAAA

   
Results: 1-25 | 26-50 | 51-59
Results: 26-50/59
CONSIDERATIONS FOR CURRENT AND FUTURE MANAGEMENT OF HEMOPHILIA AND ITS COMPLICATIONS
Authors: LUSHER JM
Citation: Jm. Lusher, CONSIDERATIONS FOR CURRENT AND FUTURE MANAGEMENT OF HEMOPHILIA AND ITS COMPLICATIONS, Haemophilia, 1(1), 1995, pp. 2-10
SAFETY AND EFFICACY OF MONOCLONAL ANTIBODY-PURIFIED FACTOR-IX CONCENTRATE FOR MANAGEMENT OF BLEEDING AND SURGICAL PROPHYLAXIS IN PREVIOUSLYTREATED CHILDREN WITH HEMOPHILIA-B
Authors: KURCZYNSKI E LUSHER JM PITEL P SHAPIRO AD BERGMAN GE
Citation: E. Kurczynski et al., SAFETY AND EFFICACY OF MONOCLONAL ANTIBODY-PURIFIED FACTOR-IX CONCENTRATE FOR MANAGEMENT OF BLEEDING AND SURGICAL PROPHYLAXIS IN PREVIOUSLYTREATED CHILDREN WITH HEMOPHILIA-B, International journal of pediatric hematology/oncology, 2(3), 1995, pp. 211-216
CHARACTERIZATION OF AUTOANTIBODIES AGAINST THE PLATELET GLYCOPROTEIN ANTIGENS IIB IIIA IN CHILDHOOD IDIOPATHIC THROMBOCYTOPENIA PURPURA/
Authors: TAUB JW WARRIER I HOLTKAMP C BEARDSLEY DS LUSHER JM
Citation: Jw. Taub et al., CHARACTERIZATION OF AUTOANTIBODIES AGAINST THE PLATELET GLYCOPROTEIN ANTIGENS IIB IIIA IN CHILDHOOD IDIOPATHIC THROMBOCYTOPENIA PURPURA/, American journal of hematology, 48(2), 1995, pp. 104-107
COMPARISON OF 6 COMMERCIAL PLASMA REFERENCES FOR FACTOR-VIII, FACTOR-IX AND VON-WILLEBRAND-FACTOR - ON BEHALF OF THE SUBCOMMITTEE FOR FACTOR-VIII AND IX OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE ISTH
Authors: KASPER CK ARONSON DL DAVIGNON G FOSTER P HILLMANWISEMAN C LUSHER JM MANCOJOHNSON M MEADE JB MONTGOMERY RR RICKLES FR WHITE GC
Citation: Ck. Kasper et al., COMPARISON OF 6 COMMERCIAL PLASMA REFERENCES FOR FACTOR-VIII, FACTOR-IX AND VON-WILLEBRAND-FACTOR - ON BEHALF OF THE SUBCOMMITTEE FOR FACTOR-VIII AND IX OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE ISTH, Thrombosis and haemostasis, 74(3), 1995, pp. 987-989
INDUCTION OF IMMUNE TOLERANCE WITH KOGENATE(TM) RECOMBINANT FACTOR-VIII (RFVIII) IN HEMOPHILIA PATIENTS WITH HIGH-TITER INHIBITORS - AN UPDATE REPORT
Authors: INWOOD MI LUSHER JM ROUSELL RH ABILDGAARD CF ARKINS S HILGARTNER MW ZIMMERMANN R HURST D
Citation: Mi. Inwood et al., INDUCTION OF IMMUNE TOLERANCE WITH KOGENATE(TM) RECOMBINANT FACTOR-VIII (RFVIII) IN HEMOPHILIA PATIENTS WITH HIGH-TITER INHIBITORS - AN UPDATE REPORT, Thrombosis and haemostasis, 73(6), 1995, pp. 1014-1014
A COMPREHENSIVE TRANSFUSION MEDICINE CURRICULUM FOR MEDICAL-STUDENTS
Authors: CABLE RG THAL SE FINK A CALHOUN L PETZ LD CROWLEY JP MOR V GOODNOUGH LT HULL A WHITSETT CF SULLIVAN C SIMPSON MB SILVER S KRUSKALL MS BRENNAN R SMITH JE BAILEY GD GOTTSCHALL JL SIMPSON DE JETER EK FLEMING GA SCHWARTZ KA BRIDGHAM R BULL RW BRIDGHAM RG ROSSI EC KENNEDY MS PEARSOL JA SPENCE RK DAVIDSON R JOHNSTON MFM STEHLING L DRACKER RA EISENSTAEDT RS GLANZ K COTTER SM FELDMAN R TOY PTCY ROSINSKI E GREENWALT TJ AMBRUSO DR HOUSE E HOWE K THAL S STRAUSS RG MITCHELL S SZYMANSKI IO ANDERSON SM LENES BA JASON H MAHAN JM WARKENTIN PI MANNING BA LEACH M SIMON TL SMITH K ODONNELL MJ COLLINS ML STRITTER FT JEFFRIES LC DISERENS D GIGER U VELEZ R PATTEN ED PETRUSA ER WESTPHAL RG MCPHERSON B MINTZ PD SHORT JG FANG WL PRICE TH WOODSON RD STONE HL MEYERS KM MINER D LUSHER JM GALLAGHER R SNYDER EL FARACLAS W HARDING F ROTH C
Citation: Rg. Cable et al., A COMPREHENSIVE TRANSFUSION MEDICINE CURRICULUM FOR MEDICAL-STUDENTS, Transfusion, 35(6), 1995, pp. 465-469
ABSTRACTS OF PAPERS PRESENTED AT THE NATIONAL HEMOPHILIA FOUNDATION -46TH ANNUAL-MEETING - OCTOBER 27-30, 1994
Authors: LUSHER JM
Citation: Jm. Lusher, ABSTRACTS OF PAPERS PRESENTED AT THE NATIONAL HEMOPHILIA FOUNDATION -46TH ANNUAL-MEETING - OCTOBER 27-30, 1994, Transfusion, 35(5), 1995, pp. 436-436
USE OF THE HIGHLY CONCENTRATED INTRANASAL SPRAY FORMULATION OF DESMOPRESSIN IN MILD HEMOPHILIA-A AND VON-WILLEBRAND DISEASE
Authors: LUSHER JM
Citation: Jm. Lusher, USE OF THE HIGHLY CONCENTRATED INTRANASAL SPRAY FORMULATION OF DESMOPRESSIN IN MILD HEMOPHILIA-A AND VON-WILLEBRAND DISEASE, Transfusion, 35(5), 1995, pp. 445-445
RECOMBINANT FVIII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY AND INHIBITORDEVELOPMENT AFTER 5 STUDY YEARS
Authors: LUSHER JM ARKIN S ABILDGAARD CF HURST D
Citation: Jm. Lusher et al., RECOMBINANT FVIII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY AND INHIBITORDEVELOPMENT AFTER 5 STUDY YEARS, Pediatric research, 37(4), 1995, pp. 161-161
PLASMA FVIII LEVELS MEASURED AFTER INFUSION OF RECOMBINANT-F-VIII (RFVIII) VARY SIGNIFICANTLY WITH DIFFERENT ASSAY-METHODS - (WILL THE REALFVIII LEVEL PLEASE STAND UP)
Authors: LUSHER JM HILLMANWISEMAN C SIMPSON P HURST D
Citation: Jm. Lusher et al., PLASMA FVIII LEVELS MEASURED AFTER INFUSION OF RECOMBINANT-F-VIII (RFVIII) VARY SIGNIFICANTLY WITH DIFFERENT ASSAY-METHODS - (WILL THE REALFVIII LEVEL PLEASE STAND UP), Blood, 86(10), 1995, pp. 755-755
TREATMENT OF INTERNAL HEMORRHAGES WITH RFVIIA IN PATIENTS WITH FVIII AND FIX INHIBITOR ANTIBODIES
Authors: LUSHER JM HEDNER U
Citation: Jm. Lusher et U. Hedner, TREATMENT OF INTERNAL HEMORRHAGES WITH RFVIIA IN PATIENTS WITH FVIII AND FIX INHIBITOR ANTIBODIES, Blood, 86(10), 1995, pp. 2430-2430
BLOOD-TRANSFUSIONS AND IMMUNOPHENOTYPIC ALTERATIONS OF LYMPHOCYTE SUBSETS IN SICKLE-CELL-ANEMIA
Authors: WONG WY POWARS DR OPERSKALSKI EA HASSETT J PARKER JW SARNAIK S PEGELOW CH HILGARTNER MW JOHNSON CS ZHOU Y KU PY MOSLEY JW BUCKLEY J HARRIS M KASPER CK LEE H NOWICKI MJ PIKE MC HYMAN C KLEINMAN SH DIETRICH SL LUSHER JM KAPLAN J SCHIFF ER FLETCHER MA TEMPLE JD TOLEDANO S ALEDORT LM KAUFMAN MF KULPA Y BROWN AR MILLER ST STEVENS CE TAYLOR PE DONEGAN E KOERPER MA BUSCH MP JOHNSON RA LEWIS BH GJERSET GF HOLLINGSWORTH CG NEMO GJ HOAK J ALTER HJ DALESSIO DJ GRADY GF HOLLAND PV ROSE NR SEEFF LB WITTES J
Citation: Wy. Wong et al., BLOOD-TRANSFUSIONS AND IMMUNOPHENOTYPIC ALTERATIONS OF LYMPHOCYTE SUBSETS IN SICKLE-CELL-ANEMIA, Blood, 85(8), 1995, pp. 2091-2097
SUMMARY OF CLINICAL-EXPERIENCE WITH RECOMBINANT FACTOR-VIII PRODUCTS - KOGENATE
Authors: LUSHER JM
Citation: Jm. Lusher, SUMMARY OF CLINICAL-EXPERIENCE WITH RECOMBINANT FACTOR-VIII PRODUCTS - KOGENATE, Annals of hematology, 68, 1994, pp. 190000003-190000006
TRANSFUSION THERAPY IN CONGENITAL COAGULOPATHIES
Authors: LUSHER JM
Citation: Jm. Lusher, TRANSFUSION THERAPY IN CONGENITAL COAGULOPATHIES, Hematology/oncology clinics of North America, 8(6), 1994, pp. 1167-1180
VIRAL SAFETY AND CLOTTING FACTOR CONCENTRATES
Authors: LAURIAN Y LUSHER JM KESSLER CM
Citation: Y. Laurian et al., VIRAL SAFETY AND CLOTTING FACTOR CONCENTRATES, Thrombosis and haemostasis, 72(4), 1994, pp. 649-649
NOMENCLATURE OF QUANTITIES AND UNITS IN THROMBOSIS AND HEMOSTASIS (RECOMMENDATION 1993) - A COLLABORATIVE PROJECT OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE INTERNATIONAL-SOCIETY-ON-THROMBOSIS-AND-HEMOSTASIS (ISTH SSC) AND THE COMMISSION COMMITTEE ON QUANTITIES AND UNITS (IN CLINICAL-CHEMISTRY) OF THE INTERNATIONAL-UNION-OF-PURE-AND-APPLIED-CHEMISTRY INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY
Authors: BLOMBACK M ABILDGAARD U VANDENBESSELAAR AMHP CLEMENTSON KJ DAHLBACK B EXNER T FRANCIS CW GAFFNEY P GRALNICK H HOYER LW JOHNSON GJ KASPER C LANE D LIJNEN HR LUSHER JM MANNUCCI PM POLLER L RAPAPORT SI SAITO H STOCKER K THOMAS D BARROWCLIFFE TW HEMKER C THORSEN S ARONSON D MANN KG MEYER D ROBERTS HR DYBKAER R JORGENSEN K OLESEN H
Citation: M. Blomback et al., NOMENCLATURE OF QUANTITIES AND UNITS IN THROMBOSIS AND HEMOSTASIS (RECOMMENDATION 1993) - A COLLABORATIVE PROJECT OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE INTERNATIONAL-SOCIETY-ON-THROMBOSIS-AND-HEMOSTASIS (ISTH SSC) AND THE COMMISSION COMMITTEE ON QUANTITIES AND UNITS (IN CLINICAL-CHEMISTRY) OF THE INTERNATIONAL-UNION-OF-PURE-AND-APPLIED-CHEMISTRY INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY, Thrombosis and haemostasis, 71(3), 1994, pp. 375-394
RESPONSE TO 1-DEAMINO-8-D-ARGININE VASOPRESSIN IN VON-WILLEBRAND DISEASE
Authors: LUSHER JM
Citation: Jm. Lusher, RESPONSE TO 1-DEAMINO-8-D-ARGININE VASOPRESSIN IN VON-WILLEBRAND DISEASE, Haemostasis, 24(5), 1994, pp. 276-284
RESPONSE TO 1-DEAMINO-8-D-ARGININE VASOPRESSIN IN VON-WILLEBRAND DISEASE
Authors: LUSHER JM
Citation: Jm. Lusher, RESPONSE TO 1-DEAMINO-8-D-ARGININE VASOPRESSIN IN VON-WILLEBRAND DISEASE, Haemostasis, 24(5), 1994, pp. 276-284
HUMAN-ANTIBODIES TO RECOMBINANT FACTOR-VIII IN HEMOPHILIACS
Authors: LUSHER JM
Citation: Jm. Lusher, HUMAN-ANTIBODIES TO RECOMBINANT FACTOR-VIII IN HEMOPHILIACS, Journal of interferon research, 14(4), 1994, pp. 173-174
RFVIIA - RESULTS OF A DOUBLE-BLIND DOSE-FINDING STUDY
Authors: LUSHER JM
Citation: Jm. Lusher, RFVIIA - RESULTS OF A DOUBLE-BLIND DOSE-FINDING STUDY, Transfusion, 34(8), 1994, pp. 728-728
TRANSFUSION TRANSMISSION OF RETROVIRUSES - HUMAN T-LYMPHOTROPIC VIRUSTYPE-I AND TYPE-II COMPARED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: DONEGAN E LEE H OPERSKALSKI EA SHAW GM KLEINMAN SH BUSCH MP STEVENS CE SCHIFF ER NOWICKI MJ HOLLINGSWORTH CG MOSLEY JW BUCKLEY JD GAIENNIE J HARRIS M KASPER CK PIKE MC SUCCAR M ZHOU Y DIETRICH SL TAYLOR ME LEE H SCHRODE J CERNEY M KROCHMAL E ANDERSON E LUSHER JM FLETCHER MA LIAN ECY ALEDORT LM HASSETT J HILGARTNER MW TAYLOR PE KOERPER MA LEWIS BH GJERSET GF NEMO GJ HOAK J
Citation: E. Donegan et al., TRANSFUSION TRANSMISSION OF RETROVIRUSES - HUMAN T-LYMPHOTROPIC VIRUSTYPE-I AND TYPE-II COMPARED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Transfusion, 34(6), 1994, pp. 478-483
EPIDEMIOLOGIC BACKGROUND AND LONG-TERM COURSE OF DISEASE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED BLOOD-DONORS IDENTIFIED BEFORE ROUTINE LABORATORY SCREENING
Authors: BUSCH MP OPERSKALSKI EA MOSLEY JW STEVENS CE SCHIFF ER KLEINMAN SH LEE H LEE M HARRIS M KASPER CK NOWICKI MJ PIKE MC STRAM D ZHOU Y DIETRICH SL LUSHER JM FLETCHER MA ALEDORT LM HASSETT J HILGARTNER MW TAYLOR PE DONEGAN E KOERPER MA LEWIS BH GJERSET GF HOLLINGSWORTH CG NEMO GJ HOAK J ALTER HJ DALESSIO DJ GRADY GF HOLLAND PV ROSE NR SEEFF LB WITTES J
Citation: Mp. Busch et al., EPIDEMIOLOGIC BACKGROUND AND LONG-TERM COURSE OF DISEASE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED BLOOD-DONORS IDENTIFIED BEFORE ROUTINE LABORATORY SCREENING, Transfusion, 34(10), 1994, pp. 858-864
USE OF PROTHROMBIN COMPLEX CONCENTRATES IN MANAGEMENT OF BLEEDING IN HEMOPHILIACS WITH INHIBITORS - BENEFITS AND LIMITATIONS
Authors: LUSHER JM
Citation: Jm. Lusher, USE OF PROTHROMBIN COMPLEX CONCENTRATES IN MANAGEMENT OF BLEEDING IN HEMOPHILIACS WITH INHIBITORS - BENEFITS AND LIMITATIONS, Seminars in hematology, 31(2), 1994, pp. 49-52
EFFECT OF LOW-PURITY AND INTERMEDIATE-PURITY CLOTTING FASTER THERAPY ON PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN CONGENITALCLOTTING DISORDERS
Authors: GJERSET GF PIKE MC MOSLEY JW HASSETT J FLETCHER MA DONEGAN E PARKER JW COUNTS RB ZHOU Y KASPER CK OPERSKALSKI EA BUCKLEY J GAIENNIE J HARRIS M LEE H NOWICKI MJ SUCCAR M KLEINMAN SH DIETRICH SL LUSHER JM SCHIFF ER LIAN ECY ALEDORT LM HILGARTNER MW STEVENS CD TAYLOR PE KOERPER MA BUSCH MP LEWIS BH GJERSET GF HOLLINGSWORTH CG NEMO GJ HOAK J ALTER HJ DALESSIO DJ GRADY GF HOLLAND PV ROSE NR SEEFF LB WITTES J
Citation: Gf. Gjerset et al., EFFECT OF LOW-PURITY AND INTERMEDIATE-PURITY CLOTTING FASTER THERAPY ON PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN CONGENITALCLOTTING DISORDERS, Blood, 84(5), 1994, pp. 1666-1671
IMMUNE STATUS OF HUMAN-IMMUNODEFICIENCY-VIRUS SEROPOSITIVE AND SERONEGATIVE HEMOPHILIACS INFUSED FOR 3.5 YEARS WITH RECOMBINANT FACTOR-VIII
Authors: MANNUCCI PM BRETTLER DB ALEDORT LM LUSHER JM ABILDGAARD CF SCHWARTZ RS HURST D JOLLY K HARRISON J ADDIEGO JE JEREB R ARKIN S ALEDORT LM FOSTER A SEREMETIS S DASANI H HARRISON J HILGARTNER MW BOARDS N INWOOD MJ CLEGG E KASPER C MOCKARY P KRILL C DERY A MILLER E LEVINE P FORSBERG A VALDEZ L JACQUES S PFAFFMAN L WARRIOR I BRACKMANN HH GRINGERI A SANTAGOSTINO E SCHARRER I LEE C ALLRED RU BOGDANOFF D DONALDSON D MACKENZIE MA BAILEY P DYLA S PENNINGTON JE ZACCARINI P LEIGH P NEUMANN R FUKUI H
Citation: Pm. Mannucci et al., IMMUNE STATUS OF HUMAN-IMMUNODEFICIENCY-VIRUS SEROPOSITIVE AND SERONEGATIVE HEMOPHILIACS INFUSED FOR 3.5 YEARS WITH RECOMBINANT FACTOR-VIII, Blood, 83(7), 1994, pp. 1958-1962
Risultati: 1-25 | 26-50 | 51-59